South Korea Artificial Intelligence (AI) in Biotechnology Market was valued at USD 0.3 Billion in 2022 and is projected to reach USD 1.2 Billion by 2030, growing at a CAGR of 19.2% from 2024 to 2030.
The rapidly growing intersection of Artificial Intelligence (AI) and biotechnology in South Korea is transforming the landscape of healthcare and life sciences. With an increasing focus on leveraging AI technologies, South Korea has become a hotbed for innovation in the biotechnology market. From drug discovery to personalized medicine, AI's role is becoming indispensable in improving research and development efficiency and accelerating the commercialization of biotech products. As AI applications continue to evolve, industries are demanding more specialized solutions to meet their unique needs.
AI in biotechnology is already making significant strides in South Korea. The country’s robust infrastructure for AI research, combined with its thriving biotech sector, creates a fertile ground for advancements in AI applications, particularly in healthcare, diagnostics, and pharmaceutical development. The demand for AI-driven biotechnology solutions is skyrocketing, with AI algorithms improving the accuracy and speed of drug discovery, reducing the cost of R&D, and even enhancing the precision of personalized treatments.
One of the most prominent areas where AI is making an impact is in genomics and bioinformatics. AI's ability to analyze vast amounts of biological data allows for quicker identification of potential therapeutic targets, which is crucial in accelerating drug development. The use of machine learning models to predict protein structures and interactions is another key development in the AI-powered biotechnology sector.
Furthermore, industries in South Korea require AI solutions that are not only highly efficient but also scalable. As the demand for personalized medicine rises, biotechnology companies need AI tools that can handle large, complex datasets, process them in real-time, and provide actionable insights. Automation and predictive analytics are crucial for these industries, particularly in streamlining the drug discovery process and optimizing clinical trial outcomes.
The biotechnology market is not only looking for AI to support R&D but also to enhance regulatory compliance and patient care. AI models are helping to predict patient responses to treatments, improving the accuracy of diagnostics, and providing healthcare professionals with deeper insights into disease mechanisms. In addition, AI solutions are increasingly being used in clinical trials to recruit participants more efficiently and analyze trial data to yield faster and more reliable results.
In conclusion, South Korea's Artificial Intelligence (AI) in biotechnology market is experiencing a dynamic transformation. With industries demanding more innovative and specialized AI-driven solutions, the country is poised to continue making substantial contributions to the global biotech landscape. As AI technologies evolve, the integration of AI into biotechnology will only become more sophisticated, bringing unprecedented benefits to healthcare, research, and development.
Get an In-Depth Research Analysis of the South Korea Artificial Intelligence (AI) in Biotechnology Market Size And Forecast [2025-2032]
Â
AstraZeneca
Abbott Laboratories
Amgen
Inc.
Atomwise
Biogen
Bristol-Myers Squibb
F. Hoffmann-La Roche Ltd.
Gilead Sciences
Inc
Johnson & Johnson Services
Inc.
Pfizer
Inc.
Merck KGaA
Novo Nordisk A/S
Novartis AG
Sanofi
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Artificial Intelligence (AI) in Biotechnology Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Artificial Intelligence (AI) in Biotechnology Market
Drug Development
Genomics
Disease Diagnostics
Personalized Medicine
Clinical Trials
Biomanufacturing
Machine Learning
Natural Language Processing (NLP)
Deep Learning
Computer Vision
Expert Systems
Pharmaceutical Companies
Biotechnology Firms
Research Institutions
Diagnostic Laboratories
Healthcare Providers
Software
Hardware
Services
Data
Regenerative Medicine
Vaccinology
Oncology
Environmental Biotechnology
Food Biotechnology
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Artificial Intelligence (AI) in Biotechnology Market Research Analysis
1. Introduction of the South Korea Artificial Intelligence (AI) in Biotechnology Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Artificial Intelligence (AI) in Biotechnology Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Artificial Intelligence (AI) in Biotechnology Market, By Type
6. South Korea Artificial Intelligence (AI) in Biotechnology Market, By Application
7. South Korea Artificial Intelligence (AI) in Biotechnology Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Artificial Intelligence (AI) in Biotechnology Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/